Mauricio Chandía

Multiparameter flow cytometry for staging of solitary bone plasmacytoma: new criteria for risk of progression to myeloma

Bruno Paiva, Mauricio Chandía, María‐Belén Vídriales et al. · Blood · 2014 · 93 citations

Minimal residual disease evaluation by flow cytometry is a complementary tool to cytogenetics for treatment decisions in acute myeloid leukaemia

María‐Belén Vídriales, Estefanía Pérez‐López, Carlota Pegenaute et al. · Leukemia Research · 2015 · 34 citations

Hematological Malignancy, Flow Cytometry, Complementary Tool +14

Different outcomes for transplant-eligible newly diagnosed multiple myeloma patients in Latin America according to the public versus private management: a GELAMM study

Camila Peña, Eloísa Riva, Natalia Schütz et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2020 · 26 citations · Full text

Transplantation Medicine, Latin America, Transplant-eligible Multiple Myeloma +16

Involvement of primary mesenchymal precursors and hematopoietic bone marrow cells from chronic myeloid leukemia patients by <i>BCR‐ABL1</i> fusion gene

Mauricio Chandía, José-María Sayagués, María Laura Gutiérrez et al. · American Journal of Hematology · 2013 · 11 citations · Full text

Hematological Malignancy, Chronic Myeloid Leukemia, Interphase Fluorescence +14